Publications

Browse a collection of academic publications and research papers, contributed to by personnel from the Unit.

ROETYNCK, S; Baratin, M; Johansson, S; Lemmers, C; Vivier, E; Ugolini, S;

2006

Immunological reviews, (2006).214, 10.1111/j.1600-065x.2006.00446.x.

Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes.

Walther, M; Woodruff, J; Edele, F; JEFFRIES, D; Tongren, JE; King, E; Andrews, L; Bejon, P; Gilbert, SC; De Souza, JB; Sinden, R; Hill, AV S; RILEY, EM;

2006

Journal of immunology (Baltimore, Md, (2006).177 8 10.4049/jimmunol.177.8.5736.

Microbiology of acute otitis media with perforation (AOMwiP) in Aboriginal children living in remote communities—monitoring the impact of 7-valent pneumococcal conjugate vaccine (7vPCV).

Leach, A; MACKENZIE, G; Hare, K; Stubbs, E; Beissbarth, J; Kennedy, M; Wilson, C; Mellon, G; Wigger, C; Tippakalipa, P; Smith-Vaughan, H; Halpin, S; Morris, P;

2006

International Congress Series, (2006).1289, 10.1016/j.ics.2005.11.078.

[NK cells and innate immunity to malaria].

ROETYNCK, S; Baratin, M; Vivier, E; Ugolini, S;

2006

Medecine sciences : M/S, (2006).22 8-9 10.1051/medsci/20062289739.

HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria.

Van Geertruyden, J-P; Mulenga, M; Mwananyanda, L; Chalwe, V; Moerman, F; Chilengi, R; Kasongo, W; Van Overmeir, C; Dujardin, J-C; Colebunders, R; Kestens, L; D'ALESSANDRO, U;

2006

The Journal of infectious diseases, (2006).194 7 10.1086/507310.

Investigation of cholesterol gallstone disease.

FORREST, K; Welch, C; Williams, E; Smart, H; Lombard, M;

2006

Lancet (London, England), (2006).368 9540 10.1016/s0140-6736(06)69412-9.

Transmission mode and distribution of parasites among groups of the social lizard Egernia stokesii.

Godfrey, SS; Bull, CM; MURRAY, K; Gardner, MG;

2006

Parasitology research, (2006).99 3 10.1007/s00436-005-0120-9.

Human NK cell education by inhibitory receptors for MHC class I.

Anfossi, N; André, P; Guia, S; Falk, CS; ROETYNCK, S; Stewart, CA; Breso, V; Frassati, C; Reviron, D; Middleton, D; Romagné, F; Ugolini, S; Vivier, E;

2006

Immunity, (2006).25 2 10.1016/j.immuni.2006.06.013.

Molecular characterisation of pneumococcal serotype 16F: Established predominant carriage and otitis media serotype in the 7vPCV era.

Marsh, RL; Smith-Vaughan, H; Beissbarth, J; Hare, K; Kennedy, M; Wigger, C; Mellon, G; Stubbs, E; Gadil, JR; Pettit, A; MACKENZIE, G; Tipakalippa, P; Morris, PS; Leach, AJ;

2006

Vaccine, (2006).25 13 10.1016/j.vaccine.2006.09.016.

RTS,S/AS02A for malaria.

BOJANG, KA;

2006

Expert review of vaccines, (2006).5 5 10.1586/14760584.5.5.611.